amifostine anhydrous has been researched along with Anorexia in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Anorexia: The lack or loss of APPETITE accompanied by an aversion to food and the inability to eat. It is the defining characteristic of the disorder ANOREXIA NERVOSA.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Raza, A | 1 |
Qawi, H | 1 |
Lisak, L | 1 |
Andric, T | 1 |
Dar, S | 1 |
Andrews, C | 1 |
Venugopal, P | 1 |
Gezer, S | 1 |
Gregory, S | 1 |
Loew, J | 1 |
Robin, E | 1 |
Rifkin, S | 1 |
Hsu, WT | 1 |
Huang, RW | 1 |
1 other study available for amifostine anhydrous and Anorexia
Article | Year |
---|---|
Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone.
Topics: Adult; Aged; Aged, 80 and over; Amifostine; Anorexia; Antineoplastic Combined Chemotherapy Protocols | 2000 |